Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.
Press releases published on June 17, 2025
Tariffs and U.S.-Canada relations are the top financial concern for seniors: new research from HOOPP and Abacus Data
GlobeNewswire
·
June 17, 2025
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Geopolitical instability and the ongoing trade dispute with the United States have emerged as a major financial concern for Canadians and is having an impact on people’s retirement planning, according to the …
Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients
GlobeNewswire
·
June 17, 2025
- 94% OS and 72% PFS observed at 6 months for atebimetinib (IMM-1-104) in combination with modified Gemcitabine/nab-paclitaxel (mGnP), N=34; median OS and PFS not yet reached - - Striking tumor reductions with 39% overall response rate and 81% disease …
Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42
GlobeNewswire
·
June 17, 2025
HUNTSVILLE, June 17, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today congratulates its strategic partner …
Astrocyte Pharmaceuticals Announces Milestones in the Fight Against Concussions: Launch of Phase 2 Clinical Trial and New $3M NIH Grant
GlobeNewswire
·
June 17, 2025
GROTON, Conn., June 17, 2025 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc., a clinical-stage biotechnology company today announced two major milestones that could change the way we protect brains from the damage caused by concussions and repeat head …
AscellaHealth Wins Business Change and Transformation Excellence Award at the Industry Eagles Awards 2025
GlobeNewswire
·
June 17, 2025
DUBLIN and BERWYN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- We are proud to announce that AscellaHealth has been awarded Gold in the Business Change and Transformation Excellence category at the Industry Eagles Awards 2025, held on 5th June 2025 at The …
Llusern Scientific Announces ISO 13485 Certification for its Point-of-Care Diagnostics System for Urinary Tract Infections
GlobeNewswire
·
June 17, 2025
CARDIFF, United Kingdom, June 17, 2025 (GLOBE NEWSWIRE) -- Llusern Scientific, a point-of-care diagnostics company, announces it has been awarded ISO 13485 certification for its Lodestar DX testing system, a rapid molecular diagnostic platform for urinary …
Captain T Cell Joins Bayer Co.Lab Berlin to Accelerate Autologous and Allogeneic TCR-T Cell Therapy Programs for Cancer Patients
GlobeNewswire
·
June 17, 2025
Berlin, Germany – June 17th, 2025 – Captain T Cell GmbH, a biotech company developing next-generation TCR-based cell therapies for patients with solid tumors, today announced that it has been selected for residency in the Bayer Co.Lab incubator in Berlin. …
Evosep Joins P4ML to Power World’s Largest Multi-Omic Human Health Study of Two Million Samples
GlobeNewswire
·
June 17, 2025
SAINT-MALO, France, June 17, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform provider for the P4ML - OMIC-Assist Study—the world’s largest multi-omic …
ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025
GlobeNewswire
·
June 17, 2025
EINDHOVEN, the Netherlands, June 17, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord …
Jyong Biotech Ltd. Announces Pricing of $20 Million Initial Public Offering
GlobeNewswire
·
June 17, 2025
New Taipei City, Taiwan, June 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly …